Femur head necrosis as a post-acute sequela of COVID-19 (Sars-Cov-2 infection)
Автор: Kandari Anirudh K.S., Bhamare Dhammapal S., Salunkhe Rahul, Sukrethan Sayooj Valiyaparambil, Shevate Ishan, Deshmukh Ashwin, Pisal Tushar, Kulkarni Ketan, Janapamala Kishore
Журнал: Гений ортопедии @geniy-ortopedii
Рубрика: Оригинальные статьи
Статья в выпуске: 2 т.28, 2022 года.
Бесплатный доступ
Introduction While the COVID-19 pandemic may still be ongoing, we have simultaneously entered into the post-acute phase of COVID-19, which comes with its own challenges. This case series reports 11 patients of COVID-19 treated with corticosteroids who subsequently developed osteonecrosis of the femoral head (ONFH). Methods All consecutive patients diagnosed on MRI with ONFH from August 2020 to May 2021 and were retrospectively COVID-19 positive were included. The treatment administered for COVID-19 was retrieved and evaluated. The patients were managed for femoral head necrosis, and results were reported. Results Overall, 11 patients developed ONFH in a total of 16 hips. The severity of femoral head necrosis depended on the dose of corticosteroid administered during COVID-19. A high dose for a longer duration resulted in a higher ONFH stage (FICAT & Arlet ). Hips in the lower grade were treated conservatively, and in the higher grade were treated surgically. The follow-up scores of patients demonstrated steady improvement. Conclusions High suspicion of femoral head necrosis has to be considered in patients treated with corticosteroids for COVID-19 as it can aid in early detection and early intervention to preserve the native femoral head.
Femur head necrosis, post-acute covid-19 syndrome, case series
Короткий адрес: https://sciup.org/142234581
IDR: 142234581
Список литературы Femur head necrosis as a post-acute sequela of COVID-19 (Sars-Cov-2 infection)
- Coronavirus disease (COVID-19). Situation report - 119 / World Health Organization. 18 May, 2020. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200518-covid-19-sitrep-119.pdf?sfvrsn=4bd9de25_4(accessed: May 19, 2020).
- Tirelli U., Taibi R., Chirumbolo S. Post COVID syndrome: a new challenge for medicine // Eur. Rev. Med. Pharmacol. Sci. 2021. Vol. 25, No 12. P. 4422-4425. DOI: 10.26355/eurrev_202106_26154.
- Short- and potential long-term adverse health outcomes of COVID-19: a rapid review / T.Y.M. Leung, A.Y.L. Chan, E.W. Chan, V.K.Y. Chan, C.S.L. Chui, B.I. Cowling, L. Gao, M.Q. Ge, I.F.N. Hung, M.S.M. Ip, P. Ip, K.K. Lau, C.S. Lau, L.K.W. Lau, W.K. Leung, X. Li, H. Luo, K.K.C. Man, V.W.S. Ng, C.W. Siu, E.Y.F. Wan, Y.K. Wing, C.S.M. Wong, K.H.T. Wong, I.C.K. Wong // Emerg. Microbes Infect. 2020. Vol. 9, No 1. P. 2190-2199. DOI: 10.1080/22221751.2020.1825914.
- Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview // Diabetes Metab. Syndr. 2021. Vol. 15, No 3. P. 869-875. DOI: 10.1016/j. dsx.2021.04.007
- Musculoskeletal Consequences of COVID-19 / N.P. Disser, AJ. De Micheli, M.M. Schonk, M.A. Konnaris, A.N. Piacentini, D.L. Edon, B.G. Toresdahl, S.A. Rodeo, E.K. Casey, C.L. Mendias // J. Bone Joint Surg. Am. 2020. Vol. 102, No 14. P. 1197-1204. DOI: 10.2106/JBJS.20.00847.
- Tsang K.W., Ooi G.C., Ho P.L. Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt? // Eur. Respir. J. 2004. Vol. 24, No 6. P. 1025-1032. DOI: 10.1183/09031936.04.00092004.
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings / C.M. Chu, V.C. Cheng, I.F. Hung, M.M. Wong, K.H. Chan, K.S. Chan, R.Y. Kao, L.L. Poon, C.L. Wong, Y. Guan, J.S. Peiris, K.Y. Yuen; HKU/UCH SARS Study Group // Thorax. 2004. Vol. 59, No 3. P. 252-256. DOI: 10.1136/thorax.2003.012658.
- Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta- analysis / R. Zhao, H. Wang, X. Wang, F. Feng // Osteoporos. Int. 2017. Vol. 28, No 3. P. 1027-1034. DOI: 10.1007/s00198-016-3824-z.
- The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting of CasE Series in Surgery (PROCESS) Guidelines / R.A.Agha, C. Sohrabi, G. Mathew, T. Franchi, A. Kerwan, N. O'Neill; PROCESS Group // Int. J. Surg. 2020. Vol. 84. P. 231-235. DOI: 10.1016/ j.ijsu.2020.11.005.
- The PROCESS 2018 statement: Updating Consensus Preferred Reporting of CasE Series in Surgery (PROCESS) guidelines / R.A. Agha, M.R. Borrelli, R. Farwana, K. Koshy, A.J. Fowler, D.P. Orgill; PROCESS Group // Int. J. Surg. 2018. Vol. 60. P. 279-282. DOI: 10.1016/j.ijsu.2018.10.031.
- Son K.B., Lee T.J., Hwang S.S. Disease severity classification and COVID-19 outcomes, Republic of Korea // Bull. World Health Organ. 2021. Vol. 99, No 1. P. 62-66. DOI: 10.2471/BLT.20.257758.
- A living WHO guideline on drugs for covid-19 / A. Agarwal, B. Rochwerg, F. Lamontagne, R.A. Siemieniuk, T. Agoritsas, L. Askie, L. Lytvyn, Y.S. Leo, H. Macdonald, L. Zeng, W. Amin, F.A.J. Barragan, F.J. Bausch, E. Burhan, C.S. Calfee, M. Cecconi, D. Chanda, V.O. Dat, A. De Sutter, B. Du, H. Geduld, P. Gee, M. Gotte, N. Harley, M. Hashimi, B. Hunt, F. Jehan, S.K. Kabra, S. Kanda, Y.J. Kim, N. Kissoon, S. Krishna, K. Kuppalli, A. Kwizera, T. Lisboa, I. Mahaka, H. Manai, G. Mino, E. Nsutebu, J. Preller, N. Pshenichnaya, N. Oadir, S. Sabzwari, R. Sarin, M. Shankar-Hari, M. Sharland, Y. Shen, S.S. Ranganathan, J.P. Souza, M. Stegemann, R. Swanstrom, S. Ugarte, S. Venkatapuram, D. Vuyiseka, A. Wijewickrama, B. Maguire, L. Tran, D. Zeraatkar, J.J. Bartoszko, L. Ge, R. Brignardello-Petersen, A. Owen, G. Guyatt, J. Diaz, L. Kawano-Dourado, M. Jacobs, P.O. Vandvik // BMJ. 2020. Vol. 370. m3379. DOI: 10.1136/bmj.m3379.
- Ficat R.P. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment // J. Bone Joint Surg. Br. 1985. Vol. 67, No 1. P. 3-9. DOI: 10.1302/0301-620X.67B1.3155745.
- Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study / P. Zhang, J. Li, H. Liu, N. Han, J. Ju, Y. Kou, L. Chen, M. Jiang, F. Pan, Y. Zheng, Z. Gao, B. Jiang // Bone Res. 2020. Vol. 8. P. 8. DOI: 10.1038/s41413-020-0084-5.
- Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up / W. Wang, N. Zhang, W. Guo, F. Gao // Int. Orthop. 2018. Vol. 42, No 7. P. 1551-1556. DOI: 10.1007/s00264-018-3907-x.
- Fatal aspergillosis in a patient with SARS who was treated with corticosteroids / H. Wang, Y. Ding, X. Li, L. Yang, W. Zhang, W. Kang // N. Engl. J. Med. 2003. Vol. 349, No 5. P. 507-508. DOI: 10.1056/NEJM200307313490519.
- Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic / S. Zhang, C. Wang, L. Shi, O. Xue // Drug Des. Devel. Ther. 2021. Vol. 15. P. 983-995. DOI: 10.2147/DDDT.S298691.
- Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms / W. Sun, Z. Li, Z. Shi, B. Wang, F. Gao, Y. Yang, W. Guo // Eur. J. Orthop. Surg. Traumatol. 2014. Vol. 24, No 4. P. 525-529. DOI: 10.1007/s00590-013-1223-0.
- Sreekanth Reddy O., Lai W.F. Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options // Chembiochem. 2021. Vol. 22, No 6. P. 939-948. DOI: 10.1002/cbic.202000595.
- Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10- year minimum follow-up with MRI / J. Nakamura, Y. Harada, K. Oinuma, S. Iida, S. Kishida, K. Takahashi // Lupus. 2010. Vol. 19, No 11. P. 1307-1314. DOI: 10.1177/0961203310372951.
- Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head / M. Shibatani, M. Fujioka, Y. Arai, K. Takahashi, K. Ueshima, M. Okamoto, N. Yoshimura, Y. Hirota, W. Fukushima, T. Kubo // Acta Orthop. 2008. Vol. 79, No 5. P. 631-636. DOI: 10.1080/17453670810016641.
- Patel M.S., Gutman M.J., Abboud J.A. Orthopaedic Considerations Following COVID-19: Lessons from the 2003 SARS Outbreak // JBJS Rev. 2020. Vol. 8, No 7. e2000052. DOI: 10.2106/JBJS.RVW.20.00052.
- The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study / K.J. Guo, F.C. Zhao, Y. Guo, F.L. Li, L. Zhu, W. Zheng // Bone Joint J. 2014. Vol. 96-B, No 2. P. 259-262. DOI: 10.1302/0301-620X.96B2.31935.
- Long-term Outcome of Short-course High-dose Glucocorticoids for Severe Acute Respiratory Syndrome (SARS): A 17-Year Follow-up in SARS Survivors / C.W. Sing, K.C.B. Tan, I.C.K. Wong, B.M.Y. Cheung, C.L. Cheung // Clin. Infect. Dis. 2021. Vol. 72, No 10. P. 1830-1833. DOI: 10.1093/ cid/ciaa992.
- Zhang B., Zhang S. Corticosteroid-Induced Osteonecrosis in COVID-19: A Call for Caution // J. Bone Miner. Res. 2020. Vol. 35, No 9. P. 1828-1829. DOI: 10.1002/jbmr.4136.
- Avascular osteonecrosis after treatment of SARS: a 3-year longitudinal study / H. Lv, S.J. de Vlas, W. Liu, T.B. Wang, Z.Y. Cao, C.P. Li, W.C. Cao, J.H. Richardus // Trop. Med. Int. Health. 2009. Vol. 14, No Suppl. 1. P. 79-84. DOI: 10.1111/j.1365-3156.2008.02187.x.
- Wang Z.O., Liu T.S., Wang J.G. The clinical research of the SARS patients diagnosed with femur head necrosis // Tianjin Med. J. 2006. Vol. 34. P. 50-51. ~
- MRI-detected bone marrow changes within 3 weeks after initiation of high-dose corticosteroid therapy: a possible change preceding the subsequent appearance of low-intensity band in femoral head osteonecrosis / Y. Kubo, T. Yamamoto, G. Motomura, N. Tsukamoto, K. Karasuyama, K. Sonoda, H. Hatanaka, T. Utsunomiya, Y. Iwamoto // Rheumatol. Int. 2015. Vol. 35, No 11. P. 1909-1912. DOI: 10.1007/s00296-015-3346-6.
- Clinical analysis of 23 cases of steroid-associated osteonecrosis of the femoral head with normal initial magnetic resonance imaging presentation / F.C. Zhao, H.X. Hu, X. Zheng, D.W. Cang, X. Liu, J.Z. Zhang, KJ. Guo // Medicine (Baltimore). 2017. Vol. 96, No 49. e8834. DOI: 10.1097/ MD.0000000000008834.
- Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview) / X.H. Xie, X.L. Wang, H.L. Yang, D.W. Zhao, L. Qin // J. Orthop. Translat. 2015. Vol. 3, No 2. P. 58-70. DOI: 10.1016/j.jot.2014.12.002.
- Prevention for glucocorticoid-induced osteonecrosis of femoral head: a long-term clinical follow-up trail / B.Y. Liu, L . Yang, B.J. Wang, Z.H. Wang, L.L. Cheng, H. Xie, X. Qiu, ZJ. Ma, D.W. Zhao // Zhonghua Yi Xue Za Zhi. 2017. Vol. 97, No 41. P. 3213-3218. DOI: 10.3760/cma.j .issn.0376-2491.2017.41.004.
- Prediction of collapse with magnetic resonance imaging of avascular necrosis of the femoral head / K. Shimizu, H. Moriya, T. Akita, M. Sakamoto, T. Suguro // J. Bone Joint Surg. Am. 1994. Vol. 76, No 2. P. 215-223. DOI: 10.2106/00004623-199402000-00007.
- A 12-year follow-up study of combined treatment of post-severe acute respiratory syndrome patients with femoral head necrosis / T. Liu, J. Ma, B. Su, H. Wang, Q. Wang, X. Ma // Ther. Clin. Risk Manag. 2017. Vol. 13. P. 1449-1454. DOI: 10.2147/TCRM.S140694.
Статья научная
